Article (Scientific journals)
Functional rescue and AI analysis of a human inactivating GPCR mutation using a small molecule
Das, Debajyoti; Wyatt, Amanda; Sivaprasad, Sarath et al.
2026In EMBO Molecular Medicine
Peer Reviewed verified by ORBi
 

Files


Full Text
Debajyoti-et-al_EMBOMolecularMedicine2026.pdf
Publisher postprint (8.28 MB) Creative Commons License - Attribution
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
AI; Calcium Imaging; Inactivating Mutation; Luteinizing Hormone Receptor; Pharmacological Chaperone; Molecular Medicine
Abstract :
[en] G protein-coupled receptors (GPCRs) carry out the majority of cellular transmembrane signaling. Many pathologies have underlying GPCR mutations, most of which cause misfolding and GPCR cell surface trafficking failure. Large libraries of existing small molecule GPCR ligands could be repurposed as pharmacological chaperones (PCs) which restore mutant GPCR folding and function, presenting an exciting alternative to complex gene repair, yet such in vivo studies are limited. Therefore, as proof-of-concept, we use one such known ligand/PC, Org42599/Org43553, to show functional rescue in mice bearing an inactivating human luteinizing hormone receptor (LHR) mutation. Mutant males had delayed puberty and Leydig cell LHR signaling impairment, however, fertility was unaffected. Mutant females had irregular estrous cycles, anovulation, abrogated ovarian LHR signaling, and complete infertility. PC treatment of mutant females restored LH signaling and estrous cyclicity. To characterize treatment efficacy, we developed an AI algorithm that reliably identified inherent differences among experimental groups, enabling functional analysis of the treatment effect in vivo. Our data set the stage to integrate AI analysis with GPCR-targeting PC molecules to treat diverse GPCR-based diseases.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Das, Debajyoti ;  Department of Pharmacology, Center for Molecular Signaling (PZMS), Center for Gender-Specific Biology and Medicine (CGBM), Saarland University School of Medicine, 66421, Homburg, Germany
Wyatt, Amanda ;  Department of Pharmacology, Center for Molecular Signaling (PZMS), Center for Gender-Specific Biology and Medicine (CGBM), Saarland University School of Medicine, 66421, Homburg, Germany
Sivaprasad, Sarath;  CISPA Helmholtz Center for Information Security, 66123, Saarbrücken, Germany
Wahl, Vanessa ;  Department of Pharmacology, Center for Molecular Signaling (PZMS), Center for Gender-Specific Biology and Medicine (CGBM), Saarland University School of Medicine, 66421, Homburg, Germany
Qiao, Sen;  Department of Pharmacology, Center for Molecular Signaling (PZMS), Center for Gender-Specific Biology and Medicine (CGBM), Saarland University School of Medicine, 66421, Homburg, Germany
Ectors, Fabien  ;  Université de Liège - ULiège > Fundamental and Applied Research for Animals and Health (FARAH) > FARAH: Santé publique vétérinaire
Moosa, Zulfiah M;  Centre for Neuroendocrinology, Department of Immunology, Faculty of Health Sciences, University of Pretoria, 0084, Pretoria, South Africa
Newton, Claire L ;  Centre for Neuroendocrinology, Department of Immunology, Faculty of Health Sciences, University of Pretoria, 0084, Pretoria, South Africa ; Deanery of Biomedical Sciences, University of Edinburgh, EH8 9XD, Edinburgh, UK
Fritz, Mario;  CISPA Helmholtz Center for Information Security, 66123, Saarbrücken, Germany
Millar, Robert P ;  Centre for Neuroendocrinology, Department of Immunology, Faculty of Health Sciences, University of Pretoria, 0084, Pretoria, South Africa. bob.millar@up.ac.za ; Deanery of Biomedical Sciences, University of Edinburgh, EH8 9XD, Edinburgh, UK. bob.millar@up.ac.za ; Institute for Infectious Diseases and Molecular Medicine, Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Observatory, 7925, Cape Town, South Africa. bob.millar@up.ac.za
Boehm, Ulrich ;  Department of Pharmacology, Center for Molecular Signaling (PZMS), Center for Gender-Specific Biology and Medicine (CGBM), Saarland University School of Medicine, 66421, Homburg, Germany. ulrich.boehm@uks.eu
Language :
English
Title :
Functional rescue and AI analysis of a human inactivating GPCR mutation using a small molecule
Publication date :
08 January 2026
Journal title :
EMBO Molecular Medicine
ISSN :
1757-4676
eISSN :
1757-4684
Publisher :
Springer Science and Business Media Deutschland GmbH, Germany
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
DFG - Deutsche Forschungsgemeinschaft
COST - European Cooperation in Science and Technology
Funding text :
The authors thank Dr. Igor Gamayun and Dr. Samer Alasmi for technical assistance. This project was supported by the Deutsche Forschungsgemeinschaft (DFG) through grants to UB (SFB/TR 152 and SFB 894), the Harry Oppenheimer Trust through an award to RM, the South African National Research Foundation (NRF) through grants to RM (105824) and CN (94008), and COST action BM1105 to UB and RM.
This project was supported by the Deutsche Forschungsgemeinschaft (DFG) through grants to UB (SFB/TR 152 and SFB 894), the Harry Oppenheimer Trust through an award to RM, the South African National Research Foundation (NRF) through grants to RM (105824) and CN (94008), and COST action BM1105 to UB and RM.
Available on ORBi :
since 28 January 2026

Statistics


Number of views
10 (0 by ULiège)
Number of downloads
6 (0 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0
OpenCitations
 
0
OpenAlex citations
 
0

Bibliography


Similar publications



Contact ORBi